Aurore Life Sciences Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
They are recognized for An integrated company with complete control of key starting materials, advanced intermediates & high-quality APIs.
One of their notable products is LEVOTHYROXINE SODIUM USP, with a corresponding US DMF Number 34044.
Remarkably, this DMF maintains an Active status since its submission on August 05, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 12, 2021, and payment made on August 06, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II